Trial · NCT06235749
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
NCT06235749, Not applicable, Recruiting, Rambam Health Care Campus
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery. Trials, record NCT06235749. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06235749
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
- NCT number
- NCT06235749
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 1,180 participants, estimated
- Lead sponsor
- Rambam Health Care Campus
- Conditions
- Elective Cesarean Delivery
- Interventions
- Calcium Gluconate 10%, sodium chloride 0.9%
- First posted
- 2024-02-01
- Last updated
- 2026-07-16
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in mean hemoglobin drop | 24 hours after the surgery | Change in mean hemoglobin drop after cesarean delivery at the Calcium gluconate arm, compared to the control arm. |
| Secondary | The rate of women with a decrease of hemoglobin levels of 2 gr/dl or more | 24 hours after the surgery | The rate of women with a decrease of hemoglobin levels of 2 gr/dl or more. |
| Secondary | additional therapy for the management of PPH | during hospitalization, an average of 4 days | additional therapy for the management of PPH |
| Secondary | Receipt of blood products. | during hospitalization, an average of 4 days | Receipt of blood products. |
| Secondary | treatment with intravenous ferrous (iron). | during hospitalization, an average of 4 days | treatment with intravenous ferrous (iron). |
| Secondary | estimated blood loss during the surgery. | during the surgery | estimated blood loss during the surgery. |
| Secondary | Hospitalization length of stay. | an average of 4 days | Hospitalization length of stay. |
| Secondary | Duration of cesarean delivery | during the surgery | Duration of cesarean delivery |
| Secondary | A composite of adverse maternal outcomes | during hospitalization, an average of 4 days | A composite of adverse maternal outcomes including at least one of the following: admission to intensive care unit (NICU), the need for a surgical treatment for uncontrolled PPH, massive blood transfusion (defined as transfusion of ≥10 units red blood cells (RBCs) in 24 hours, disseminated intravascular coagulation (DIC), and death. |
| Secondary | Endometritis or antibiotic treatment following CD. | during hospitalization, an average of 4 days | Endometritis or antibiotic treatment following CD. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers9
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06235749
GET https://conductscience.org/api/trials/v1/NCT06235749/registered